Effect of the 5-HT3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure
- PMID: 7604151
- DOI: 10.1007/BF02246222
Effect of the 5-HT3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure
Abstract
The effect of the 5-HT3 antagonist ondansetron on ethanol self-administration was examined in a limited access paradigm. Acute administration of ondansetron (0.01 and 0.1 mg/kg) reduced ethanol intake in male Wistar rats by 35%, whilst water intake was unaffected. Both a lower (0.001 mg/kg) and higher dose (1 mg/kg) of ondansetron failed to modify ethanol consumption. Ondansetron did not, however, alter the pharmacokinetic profile of an orally administered dose of ethanol (1 g/kg) over the same dose range. To examine the generality of these findings and to determine if tolerance would develop to the suppressant effects of ondansetron on ethanol intake, male C57BL/6 mice were treated with ondansetron (0.001, 0.01 and 0.1 mg/kg) over 22 days, 30 min prior to scheduled access to ethanol. Both 0.01 and 0.1 mg/kg doses reduced ethanol intake; however, water intake was not altered by either dose. This finding confirms and extends the generality of the effects of 5-HT3 receptor antagonists on ethanol intake across different species and different paradigms of ethanol consumption. More importantly, the present study shows that the reduction in ethanol intake induced by ondansetron was maintained even after a prolonged period of treatment and is not due to an alteration in the absorption or metabolism of ethanol.
Similar articles
-
Evidence that the amygdala is involved in the inhibitory effects of 5-HT3 receptor antagonists on alcohol drinking in rats.Alcohol. 1995 Jul-Aug;12(4):387-91. doi: 10.1016/0741-8329(95)00023-k. Alcohol. 1995. PMID: 7546338
-
Interaction between opiate and 5-HT3 receptor antagonists in the regulation of alcohol intake.Alcohol Alcohol Suppl. 1994;2:545-9. Alcohol Alcohol Suppl. 1994. PMID: 8974381
-
Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse.Psychopharmacology (Berl). 2011 Sep;217(1):3-12. doi: 10.1007/s00213-011-2253-0. Epub 2011 Mar 22. Psychopharmacology (Berl). 2011. PMID: 21424693 Free PMC article.
-
Serotonin3 receptor antagonism of alcohol intake: effects of drinking conditions.Alcohol. 1998 May;15(4):291-8. doi: 10.1016/s0741-8329(97)00132-8. Alcohol. 1998. PMID: 9590513
-
Pharmacokinetic profile of the selective 5-HT3 receptor antagonist ondansetron in the rat: an original study and a minireview of the behavioural pharmacological literature in the rat.Can J Physiol Pharmacol. 2020 Jul;98(7):431-440. doi: 10.1139/cjpp-2019-0551. Epub 2020 Feb 4. Can J Physiol Pharmacol. 2020. PMID: 32017606 Review.
Cited by
-
Role of the serotonergic system in alcohol dependence: from animal models to clinics.Prog Mol Biol Transl Sci. 2011;98:401-43. doi: 10.1016/B978-0-12-385506-0.00010-7. Prog Mol Biol Transl Sci. 2011. PMID: 21199778 Free PMC article. Review.
-
Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.CNS Drugs. 2004;18(15):1105-18. doi: 10.2165/00023210-200418150-00005. CNS Drugs. 2004. PMID: 15581381 Review.
-
Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.Drugs. 1996 Nov;52(5):773-94. doi: 10.2165/00003495-199652050-00010. Drugs. 1996. PMID: 9118822 Review.
-
Effects of dexfenfluramine and 5-HT3 receptor antagonists on stress-induced reinstatement of alcohol seeking in rats.Psychopharmacology (Berl). 2006 May;186(1):82-92. doi: 10.1007/s00213-006-0346-y. Epub 2006 Mar 7. Psychopharmacology (Berl). 2006. PMID: 16521030
-
Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.Addict Biol. 2017 May;22(3):581-615. doi: 10.1111/adb.12349. Epub 2016 Feb 1. Addict Biol. 2017. PMID: 26833803 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical